V. Rustgi
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Carcinogens and Genotoxicity Assessment
- Cancer Genomics and Diagnostics
Papers in
- Hepatology 13
- Hepatitis C virus research 12
- Hepatocellular Carcinoma Treatment and Prognosis 1
-
- Gastroesophageal reflux and treatments 1
- Co-authors
- Claudia T. Martorell (1 shared paper)Greg T. Everson (1 shared paper)Tao Guo (1 shared paper)Megan Wind‐Rotolo (1 shared paper)Anna Suk-Fong Lok (1 shared paper)Dennis M. Grasela (1 shared paper)Mark Sulkowski (2 shared papers)Fiona McPhee (1 shared paper)
- Journals
- Journal of Hepatology (9 papers)The Lancet (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)Hepatology (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
V. Rustgi
14 papers receiving 557 citations
Peers
Comparison fields: 5 of 41
- Hepatology 304
- Cancer Research 100
- Oncology 124
- Gastroenterology 28
- Epidemiology 66
Countries citing papers authored by V. Rustgi
This map shows the geographic impact of V. Rustgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Rustgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Rustgi more than expected).
Fields of papers citing papers by V. Rustgi
This network shows the impact of papers produced by V. Rustgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Rustgi. The network helps show where V. Rustgi may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Rustgi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 389 | |
| 2 | 2011 | 53 | |
| 3 | 2011 | 40 | |
| 4 | 2013 | 30 | |
| 5 | 1993 | 28 | |
| 6 | 2009 | 19 | |
| 7 | 2006 | 13 | |
| 8 | 2009 | 11 | |
| 9 | 2001 | 7 | |
| 10 | Probability of Sustained Virologic Response (SVR) Is Associated With the Magnitude of HCV RNA Reduction at Week 4 of Treatment With Peginterferon (PEG) Plus Ribavirin (RBV): Results of the IDEAL Trial | 2008 | 2 |
| 11 | A phase II randomized, double-blind, placebo-controlled, multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin | 2001 | 1 |
| 12 | 2001 | 1 | |
| 13 | 2003 | 1 | |
| 14 | 2007 | 1 |
About V. Rustgi
V. Rustgi is a scholar working on Hepatology, Gastroenterology, Oncology, Epidemiology and Nuclear Energy and Engineering, having authored 14 papers that have together received 596 indexed citations. Recurring topics across this work include Hepatitis C virus research (12 papers), Gastroesophageal reflux and treatments (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Hepatitis B Virus Studies (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Hepatology (304 citations), Cancer Research (100 citations), Oncology (124 citations), Gastroenterology (28 citations) and Epidemiology (66 citations). V. Rustgi has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Claudia T. Martorell, Greg T. Everson, Tao Guo, Megan Wind‐Rotolo, Anna Suk-Fong Lok, Dennis M. Grasela, Mark Sulkowski, Fiona McPhee, Dessislava I. Dimitrova and Robert Reindollar. Their work appears in journals such as Journal of Hepatology, The Lancet, Alimentary Pharmacology & Therapeutics and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.